SCHEMBL7020201

SCHEMBL7020201

CCSc1ncc(C)c(Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
MAPT P10636 8/20 0.42
ALDH1A1 P00352 5/20 0.40
MEN1 O00255 2/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
TDP1 Q9NUW8 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 2/20 0.38
HPGD P15428 1/20 0.38
POLB P06746 3/20 0.38
PLA2G1B P04054 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
THRB P10828 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 2/20 0.36
HASPIN Q8TF76 1/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3257090 0.78 KMT2A (0.46) KMT2AMAPTALDH1A1MEN1CYP1A2
SCHEMBL7020481 0.77 KMT2A (0.41) KMT2AMAPTALDH1A1MEN1L3MBTL1
SCHEMBL6394361 0.76 L3MBTL1 (0.68) KMT2AMAPTALDH1A1MEN1L3MBTL1
SCHEMBL6392624 0.76 RAB9A (0.53) KMT2AMAPTALDH1A1MEN1L3MBTL1
SCHEMBL20555223 0.75 MBOAT4 (0.38) KMT2AMAPTALDH1A1MEN1L3MBTL1
SCHEMBL7022601 0.75 KMT2A (0.47) KMT2AMAPTALDH1A1MEN1L3MBTL1
SCHEMBL6393823 0.75 MAPT (0.70) KMT2AMAPTALDH1A1MEN1L3MBTL1
SCHEMBL6393377 0.74 KMT2A (0.58) KMT2AMAPTALDH1A1L3MBTL1TDP1
SCHEMBL10559871 0.74 ALDH1A1 (0.45) KMT2AMAPTALDH1A1MEN1L3MBTL1
SCHEMBL22114663 0.74 RPS6KA5 (0.34) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed